Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ACN
|
Angie Y Park
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 685 Reduced 7.32% |
$243,127
$354.93 p/Share
|
Jan 17
2025 |
|
ACN
|
Julie Spellman Sweet
Chair and CEO |
SELL
Open market or private sale
|
Direct | 2,497 Reduced 7.96% |
$886,310
$354.95 p/Share
|
Jan 17
2025 |
|
BDX
|
Michael David Garrison
EVP & President, Medical |
SELL
Open market or private sale
|
Direct | 597 Reduced 9.72% |
$141,196
$236.51 p/Share
|
Jan 17
2025 |
|
SCWO
|
Yaacov Nagar |
SELL
Open market or private sale
|
Direct | 114,998 Reduced 0.31% |
$68,998
$0.6 p/Share
|
Jan 17
2025 |
|
MRVL
|
Mark Casper
EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 7,755 Reduced 100.0% |
$954,485
$123.08 p/Share
|
Jan 17
2025 |
|
ADAP
|
Adrian Rawcliffe
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 30,601 Reduced 40.84% |
$17,748
$0.58 p/Share
|
Jan 17
2025 |
|
ADAP
|
William C Bertrand Jr
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 5,584 Reduced 42.65% |
$3,238
$0.58 p/Share
|
Jan 17
2025 |
|
ADAP
|
John Lunger
Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct | 5,584 Reduced 42.65% |
$3,238
$0.58 p/Share
|
Jan 17
2025 |
|
ADAP
|
Elliot Norry
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 5,584 Reduced 42.65% |
$3,238
$0.58 p/Share
|
Jan 17
2025 |
|
COMP
|
Robert L. Reffkin
Chairman and CEO |
SELL
Open market or private sale
|
Direct | 42,717 Reduced 2.14% |
$294,747
$6.9 p/Share
|
Jan 17
2025 |
|
SKYH
|
Boston Omaha Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 7,861 Reduced 0.07% |
$89,300
$11.36 p/Share
|
Jan 17
2025 |
|
MDGL
|
Shannon T Kelley
General Counsel |
SELL
Open market or private sale
|
Direct | 277 Reduced 3.47% |
$75,734
$273.41 p/Share
|
Jan 17
2025 |
|
MDGL
|
Rebecca Taub
Pres., R&D, and CMO |
SELL
Open market or private sale
|
Direct | 1,689 Reduced 0.37% |
$461,789
$273.41 p/Share
|
Jan 17
2025 |
|
MDGL
|
Robert E. Waltermire
Senior VP, Chief Pharma Dev. |
SELL
Open market or private sale
|
Direct | 442 Reduced 8.04% |
$120,847
$273.41 p/Share
|
Jan 17
2025 |
|
ONTF
|
Steven Vattuone
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,022 Reduced 0.19% |
$6,643
$6.5 p/Share
|
Jan 17
2025 |
|
TEM
|
Bradley A Keywell
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 265,000 Reduced 0.0% |
$9,394,250
$35.45 p/Share
|
Jan 17
2025 |
|
TEAM
|
Michael Cannon Brookes
CEO, Co-Founder |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,022,686
$254.49 p/Share
|
Jan 17
2025 |
|
TEAM
|
Scott Farquhar |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,022,686
$254.49 p/Share
|
Jan 17
2025 |
|
TEAM
|
Anutthara Bharadwaj
President |
SELL
Open market or private sale
|
Direct | 1,520 Reduced 0.72% |
$394,972
$259.85 p/Share
|
Jan 17
2025 |
|
ULCC
|
Barry Biffle
CEO |
SELL
Open market or private sale
|
Direct | 273,000 Reduced 25.05% |
$2,304,120
$8.44 p/Share
|
Jan 17
2025 |
|
AGBAR
|
Robert E. Diamond Jr. |
SELL
Open market or private sale
|
Indirect | 120,000 Reduced 0.0% |
$295,200
$2.46 p/Share
|
Jan 17
2025 |
|
PDEX
|
Raymond E Cabillot
Director |
SELL
Open market or private sale
|
Indirect | 6,820 Reduced 0.0% |
$305,467
$44.79 p/Share
|
Jan 17
2025 |
|
LWAY
|
Ludmila Smolyansky |
SELL
Open market or private sale
|
Indirect | 12,034 Reduced 0.0% |
$271,366
$22.55 p/Share
|
Jan 17
2025 |
|
ETD
|
M Farooq Kathwari
Chairman, President & CEO |
SELL
Open market or private sale
|
Indirect | 700 Reduced 0.0% |
$20,069
$28.67 p/Share
|
Jan 17
2025 |
|
ETD
|
M Farooq Kathwari
Chairman, President & CEO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.6% |
$286,700
$28.67 p/Share
|
Jan 17
2025 |
|
EXFY
|
David Michael Barrett
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 32,473 Reduced 0.0% |
$110,732
$3.41 p/Share
|
Jan 17
2025 |
|
HGTY
|
Robert I Kauffman
Director |
SELL
Open market or private sale
|
Indirect | 2,407 Reduced 0.0% |
$23,323
$9.69 p/Share
|
Jan 17
2025 |
|
COIN
|
Alesia J Haas
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 13.84% |
$6,000,000
$300.0 p/Share
|
Jan 17
2025 |
|
AVMR
|
Sudhir Srivastava
Chairman and CEO |
SELL
Open market or private sale
|
Indirect | 364,431 Reduced 0.0% |
$499,270
$1.37 p/Share
|
Jan 17
2025 |
|
DRCT
|
Mistelle Locke
Director |
SELL
Open market or private sale
|
Direct | 1,773 Reduced 4.73% |
$2,304
$1.3 p/Share
|
Jan 16
2025 |
|
QNTO
|
Robert J Phillips
Director |
SELL
Open market or private sale
|
Indirect | 1 Reduced 0.0% |
$10
$10.3 p/Share
|
Jan 16
2025 |
|
PNRG
|
Robert De Rothschild |
SELL
Open market or private sale
|
Indirect | 412 Reduced 0.0% |
$87,916
$213.39 p/Share
|
Jan 16
2025 |
|
SGHT
|
Paul Badawi
President and CEO |
SELL
Open market or private sale
|
Direct | 24,819 Reduced 0.44% |
$72,471
$2.92 p/Share
|
Jan 16
2025 |
|
OWLT
|
Amanda Crawford
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 182 Reduced 0.12% |
$782
$4.3 p/Share
|
Jan 16
2025 |
|
OWLT
|
Jonathan Harris
President & CRO |
SELL
Open market or private sale
|
Direct | 7,740 Reduced 2.68% |
$33,282
$4.3 p/Share
|
Jan 16
2025 |
|
HRMY
|
Jeffrey Dierks
CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 29,475 Reduced 100.0% |
$1,102,659
$37.41 p/Share
|
Jan 16
2025 |
|
RDDT
|
Jennifer L. Wong
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 33,334 Reduced 2.17% |
$5,798,449
$173.95 p/Share
|
Jan 16
2025 |
|
KRUS
|
Seitaro Ishii |
SELL
Open market or private sale
|
Direct | 6,918 Reduced 84.05% |
$574,401
$83.03 p/Share
|
Jan 16
2025 |
|
SYM
|
Michael David Dunn
Officer |
SELL
Open market or private sale
|
Indirect | 13,114 Reduced 0.0% |
$422,139
$32.19 p/Share
|
Jan 16
2025 |
|
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 35,921 Reduced 0.0% |
$22,021,728
$613.06 p/Share
|
Jan 16
2025 |
|
JAMF
|
Anthony Grabenau
CAO |
SELL
Open market or private sale
|
Direct | 3,706 Reduced 9.97% |
$52,365
$14.13 p/Share
|
Jan 16
2025 |
|
MARA
|
Frederick G Thiel
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 27,505 Reduced 0.67% |
$495,365
$18.01 p/Share
|
Jan 16
2025 |
|
LUNG
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct | 2,326 Reduced 0.22% |
$15,188
$6.53 p/Share
|
Jan 16
2025 |
|
RBLX
|
Amy Marie Rawlings
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 5,879 Reduced 7.22% |
$382,135
$65.0 p/Share
|
Jan 16
2025 |
|
TYRA
|
Nina S Kjellson |
SELL
Open market or private sale
|
Indirect | 7,779 Reduced 0.0% |
$126,719
$16.29 p/Share
|
Jan 16
2025 |
|
RBLX
|
Mark Reinstra
Chief Legal Off. & Corp. Sec. |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 15.1% |
$3,249,000
$64.98 p/Share
|
Jan 16
2025 |
|
CARG
|
Langley Steinert
Executive Chair |
SELL
Open market or private sale
|
Indirect | 5,042 Reduced 0.0% |
$189,831
$37.65 p/Share
|
Jan 16
2025 |
|
CARG
|
Langley Steinert
Executive Chair |
SELL
Open market or private sale
|
Direct | 45,407 Reduced 5.11% |
$1,709,573
$37.65 p/Share
|
Jan 16
2025 |
|
AGYS
|
Kaufman 2012 Descendants Trust, David N. Smith, Trustee |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 2.77% |
$1,002,825
$133.71 p/Share
|
Jan 16
2025 |
|
RYAN
|
Nicholas Dominic Cortezi
Director |
SELL
Open market or private sale
|
Indirect | 35,000 Reduced 0.0% |
$2,337,300
$66.78 p/Share
|
Jan 16
2025 |